Assessment of vocal quality following treatment of advanced pharyngo-laryngeal carcinoma with a protocol of organ preservation

被引:2
|
作者
Morato-Galan, Marta [1 ]
Caminero Cueva, Maria Jesus [2 ]
Pablo Rodrigo, Juan [1 ,3 ]
Suarez Nieto, Carlos [1 ,3 ]
Nunez-Batalla, Faustino [1 ]
机构
[1] Hosp Univ Cent Asturias, Serv Otorrinolaringol, Oviedo, Asturias, Spain
[2] Hosp Univ Cent Asturias, Serv Oncol Radioterap, Oviedo, Asturias, Spain
[3] Univ Oviedo, Inst Univ Oncol Principado Asturias, Oviedo, Asturias, Spain
来源
ACTA OTORRINOLARINGOLOGICA ESPANOLA | 2014年 / 65卷 / 05期
关键词
Head and neck cancer; Voice analysis; Functional outcomes;
D O I
10.1016/j.otorri.2013.12.005
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Introduction and objectives: Advanced laryngeal and pharyngeal cancer, as well as methods to treat them, have a direct impact on voice function, speech communication and deglutition. Such alterations in function can influence employability and general quality of life. Patients and methods: To characterise the vocal status of the patients treated with an organ preservation protocol, we report the voice outcomes of 17 patients who were alive and disease free at the time of the survey, with a minimum follow-up of 6 months, after a combination of radiotherapy and chemotherapy to treat advanced cancer. Objective voice assessment by means of spectrographic analysis, the GRBAS perceptual analysis system and the Voice Handicap Index was the methodology followed, which we suggest could be used in future large-scale investigations. Results: Normal or slightly dysphonic voices were observed in 5 patients (29.4%) and moderate/severe in 12 (70.6%). Spectrographically, the 17 samples were classified as normal in 4 cases (23.4%), Grade I in 3 cases (17.6%), Grade II in 3 (17.6%), Grade III in 4 (23.5%) and Grade IV in 2 (11.7%). The Voice Handicap Index questionnaire, which was completed by the patients themselves, gave normal results in all the patients except for 4 (23.5%). Conclusions: The voice acoustic analysis of this series shows that the damage related to the organ-preservation protocol displays a relatively wide range of voice function outcomes. To characterise the vocal status of these patients reliably, we propose using homogeneous instruments (spectrography, GRBAS scale, Maximum Phonation Time and Voice Handicap Index) in future meta-analyses. (C) 2013 Elsevier Espana, S.L.U. y Sociedad Espanola de Otorrinotaringologia y Patologia CervicoFacial. All rights reserved.
引用
收藏
页码:283 / 288
页数:6
相关论文
共 50 条
  • [41] SWALLOWING FUNCTION FOLLOWING MULTISPECIALTY ORGAN PRESERVATION TREATMENT OF ADVANCED HEAD AND NECK-CANCER
    KARNELL, MP
    MACCRACKEN, E
    MORAN, WJ
    VOKES, E
    HARAF, D
    PANJE, WR
    ONCOLOGY REPORTS, 1994, 1 (03) : 597 - 601
  • [42] Assessment of Quality of Life in Rectal Cancer with Organ-Preservation Treatment: Are We There yet?
    Baird, P.
    Steinke, J. D.
    Minnaar, H. S.
    Stewart, A. J.
    CLINICAL ONCOLOGY, 2023, 35 (02) : E110 - E120
  • [43] Expression of Bcl-2 family proteins in advanced laryngeal squamous cell carcinoma: Correlation with response to chemotherapy and organ preservation
    Trask, DK
    Wolf, GT
    Bradford, CR
    Fisher, SG
    Devaney, K
    Johnson, M
    Singleton, T
    Wicha, M
    LARYNGOSCOPE, 2002, 112 (04): : 638 - 644
  • [44] Clinical Tools for Rectal Cancer Response Assessment following Neoadjuvant Treatment in the Era of Organ Preservation
    Stefanou, Amalia J.
    Dessureault, Sophie
    Sanchez, Julian
    Felder, Seth
    CANCERS, 2023, 15 (23)
  • [45] Evolution of Nutritional Status in Patients with Advanced Head and Neck Cancer Undergoing Surgical Treatment or Organ Preservation Protocol
    Silva, Naira Marceli Fraga
    Carvalho, Ingrid Roberta de Azevedo
    Lopes, Lilian Pinheiro
    Menezes, Taysa Machado
    Guandalini, Valdete Regina
    Capuzzo, Renato de Castro
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2022, 74 (03): : 852 - 859
  • [46] Neo-adjuvant (primary) organ-preserving chemotherapy in the management of locally advanced laryngeal carcinoma: Larynx preservation and clinical response
    Mantovani, G
    Gebbia, V
    Proto, E
    Cossu, F
    Bianchi, A
    Curreli, L
    Ghiani, M
    Massa, E
    Astara, G
    Lampis, B
    Dessi, D
    Santona, MC
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1996, 9 (05) : 1035 - 1043
  • [47] Neo-adjuvant (primary) organ-preserving chemotherapy in the management of locally advanced laryngeal carcinoma: Larynx preservation and clinical response
    Mantovani, G
    Curreli, L
    Bianchi, A
    Ghiani, M
    Astara, G
    Lampis, B
    Proto, E
    Cossu, F
    Gebbia, V
    10TH MEDITERRANEAN CONGRESS OF CHEMOTHERAPY, 1996, : 563 - 567
  • [48] Laryngeal preservation by treatment with induction chemotherapy and radiotherapy protocol for stage III & IV carcinoma larynx - results of a pilot study
    Thakar, A
    Bahadur, S
    Tandon, DA
    Ranganathan, A
    Rath, GK
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 1999, 113 (05): : 433 - 438
  • [49] Functional outcomes following treatment for advanced laryngeal cancer - Part I Voice preservation in advanced laryngeal cancer - Part II Laryngectomy rehabilitation: The state of the art in the VA system
    Hillman, RE
    Walsh, MJ
    Fisher, SG
    Wolf, GT
    Hong, WK
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1998, 107 (05): : 2 - 27
  • [50] Clinical profile and treatment outcomes of locally advanced carcinoma larynx treated with organ preservation approach: A retrospective analysis
    Kainickal, C. T.
    Fasaludeen, A.
    Kumar, R. R.
    Rafi, M.
    George, P.
    Kunnambath, R.
    ANNALS OF ONCOLOGY, 2021, 32 : S794 - S794